BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2022. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $151 | -98.3% | 3 | -97.9% | 0.00% | -100.0% |
Q2 2023 | $8,975 | +6548.1% | 142 | +4633.3% | 0.00% | – |
Q1 2023 | $135 | -89.7% | 3 | -90.0% | 0.00% | – |
Q4 2022 | $1,314 | +31.4% | 30 | +42.9% | 0.00% | – |
Q3 2022 | $1,000 | -66.7% | 21 | -69.6% | 0.00% | – |
Q2 2022 | $3,000 | +200.0% | 69 | +666.7% | 0.00% | – |
Q1 2022 | $1,000 | 0.0% | 9 | -35.7% | 0.00% | – |
Q4 2021 | $1,000 | -75.0% | 14 | -65.0% | 0.00% | -100.0% |
Q3 2021 | $4,000 | +300.0% | 40 | +344.4% | 0.00% | – |
Q2 2021 | $1,000 | -50.0% | 9 | -64.0% | 0.00% | – |
Q1 2021 | $2,000 | – | 25 | +525.0% | 0.00% | – |
Q4 2020 | $0 | – | 4 | 0.0% | 0.00% | – |
Q3 2020 | $0 | – | 4 | 0.0% | 0.00% | – |
Q2 2020 | $0 | -100.0% | 4 | -99.6% | 0.00% | -100.0% |
Q1 2020 | $56,000 | +600.0% | 969 | +822.9% | 0.01% | +800.0% |
Q4 2019 | $8,000 | -69.2% | 105 | -70.8% | 0.00% | -75.0% |
Q3 2019 | $26,000 | -21.2% | 359 | 0.0% | 0.00% | -20.0% |
Q2 2019 | $33,000 | – | 359 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 581,768 | $25,487,256 | 9.57% |
Casdin Capital, LLC | 1,477,800 | $64,742,418 | 5.02% |
Nextech Invest Ltd. | 188,228 | $8,246,269 | 3.28% |
DAFNA Capital Management LLC | 261,235 | $11,444,705 | 3.22% |
Rock Springs Capital Management LP | 1,891,510 | $82,867,053 | 1.99% |
HealthCor Management, L.P. | 30,000 | $1,314,300 | 1.20% |
EFG Asset Management (North America) Corp. | 110,853 | $4,766,679 | 1.07% |
Novo Holdings A/S | 370,000 | $16,209,700 | 1.01% |
SECTORAL ASSET MANAGEMENT INC | 115,900 | $5,077,579 | 0.98% |
EMERALD MUTUAL FUND ADVISERS TRUST | 305,709 | $13,393,111 | 0.83% |